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The Nef protein of Simian immunodeficiency virus (SIV) associates with multiple T lymphocyte signaling proteins, including
the T cell receptor (TCR)  chain. We demonstrate here that these interactions are conserved and highly specific. Nefs
derived from genetically diverse strains of SIV (SIVmac239, SIVsmmPBj, and SIVsmmB670) all interacted with TCR  on two
separate domains, referred to as SIV Nef interaction domains (SNIDs), as examined in both yeast two-hybrid and glutathione-
S-transferase (GST) fusion protein pull-down assays. Multiple HIV-1 Nefs were examined and none interacted with TCR . In
contrast, HIV-2UC1 Nef, similar to SIV Nef, interacted with TCR  on two domains, although only the SIV Nefs potently reduced
cell-surface expression of the TCR/CD3 complex in T cells. In addition, we examined the abilities of SIV, HIV-2, and HIV-1 Nefs
to interact with the cytoplasmic domains of other signaling molecules including CD3, CD3, and FcRI, which also contain
YxxL motifs, and determined that SIV and HIV-2 Nefs interacted only with TCR , whereas HIV-1 Nef did not interact with any
signal-transducing cytoplasmic domain examined. Last, to gain further insight into the mechanism by which Nef down-
modulates the TCR/CD3 complex, we mutated or deleted regions on Nef involved in endocytosis, localization of Nef to the
plasma membrane, interaction with cellular kinases, or that were conserved among multiple strains of SIV. Mutation of the
myristoylation site and a conserved region surrounding a putative PKC phosphorylation site were the only mutations that
abrogated Nef-mediated down-modulation of the TCR/CD3 complex. These findings demonstrate there is a spectrum of
associations between SIV, HIV-2, and HIV-1 Nefs, and the TCR/CD3 complex, and suggest that down-modulation of the
TCR/CD3 complex occurs via association with subsets of cellular proteins that are different from those involved in CD4 andINTRODUCTION
Ever since it was originally shown that infection with
nef-defective Simian immunodeficiency virus (SIV) leads
to an attenuated disease course in rhesus macaques
(Kestler et al., 1991), much effort has focused on the
contribution of the nef gene to SIV and Human immuno-
deficiency virus (HIV) pathogenesis. Although Nef is an
important viral factor for the maintenance of high viral
loads and the induction of disease in adult macaques,
the exact mechanism(s) by which Nef exerts its function
in vivo remains unclear.
Nef is a 27- to 34-kDa protein that is N-myristoylated
(Franchini et al., 1986; Harris, 1996) and is thus targeted
to the inner cell surface of the plasma membrane. SIV,
HIV-2, and HIV-1 Nefs generally exhibit a number of
1 Present address: Department of Cancer Immunology and AIDS,
Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
02115.
2 Corresponding author. Postal address: Department of Infectious
Diseases and Microbiology, Graduate School of Public Health, 130All rights reserved.conserved activities, such as down-modulation of cell-
surface CD4 (Aiken et al., 1994; Anderson et al., 1993;
Benson et al., 1993; Garcia and Miller, 1991; Mariani and
Skowronski, 1993) and major histocompatability complex
antigen I (MHC I) (Collins et al., 1998; Le Gall et al., 1998;
Schwartz et al., 1996), enhancement of virion infectivity
(Miller et al., 1994; Spina et al., 1994), and interference
with signal transduction and protein trafficking pathways
(for recent reviews see Herna and Saksela, 2000; Piguet
and Trono, 1999). In addition, Nef can cause a state of
activation in the infected host cell (Nunn and Marsh,
1996; Baur et al., 1994a). For example, Nef induces a
transcriptional state in T lymphocytes that is nearly iden-
tical to that present in CD3-stimulated T lymphocytes
(Simmons et al., 2001) and the presence of Nef in lipid
rafts is required for Nef-mediated hyperinduction of NF-
B, NFAT, IL-2, and HIV-1 long-terminal repeat reporters
following stimulation through CD3 and CD28 (Wang et
al., 2000).
The T cell receptor (TCR)/CD3 complex is composed
of the clonotypic  heterodimer, the CD3  and 
heterodimers, and the  homodimer (reviewed in AlcoverCD28 down-modulation. © 2002 Elsevier Science (USA)
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and Alarcon, 2000). In comparison to the other compo-d activ
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nents of the TCR, the  chain is synthesized in limiting
amounts (Klausner et al., 1989). Failure of the  ho-
modimer to associate with the other components of the
TCR early in its biogenesis results in retention of the
incomplete TCR complex in the endoplasmic reticulum
and inhibition of its transport to the plasma membrane
(Klausner et al., 1989; Sussman et al., 1988). SIVmac Nef
(Bell et al., 1998; Schaefer et al., 2000; Howe et al., 1998)
and HIV-2 Nef (Howe et al., 1998) interact with the  chain
of the TCR complex in yeast two-hybrid and pull-down
assays, and through different approaches HIV-1 Nef also
appears to associate with TCR  (Xu et al., 1999). Anal-
ysis of the interaction between SIVmacJ5 Nef and TCR 
demonstrated that SIVmac Nef interacts with two non-
overlapping, homologous domains on the cytoplasmic
domain of TCR  and down-modulates the TCR/CD3
complex (Bell et al., 1998; Schaefer et al., 2000). The two
SIV Nef interaction domains (SNIDs) (Schaefer et al.,
2000) on TCR , which are targeted by SIVmacJ5 Nef,
encompass portions of the first and second immunore-
ceptor tyrosine-based activation motifs (ITAMs), respec-
tively. ITAMs are critical phosphorylation-dependent sig-
naling motifs involved in membrane-proximal events in
multiple T and B cell signaling cascades and are also
internalization motifs involved in TCR/CD3 endocytosis
(reviewed in Alcover and Alarcon, 2000). Alanine-scan-
ning mutagenesis has identified the minimal Nef-binding
sequences of SNID-1 and SNID-2 to be YNELNL and
YSEIGM, respectively (Schaefer et al., 2000).
HIV and SIV Nefs down-modulate the cell-surface ex-
pression of CD4 and MHC I (Collins et al., 1998; Schwartz
et al., 1995). The mechanism by which Nef mediates
down-modulation of CD4 is posttranslational and in-
volves accelerated endocytosis from the cell surface, as
well as some degree of diversion from the Golgi to the
endosomes (Aiken et al., 1994; Mangasarian et al., 1997;
Schwartz et al., 1995, 1996). Nef most likely interacts
simultaneously with its cell-surface targets, such as
CD4, and with components of the endocytic machinery.
Both HIV and SIV Nefs interact with adaptor protein (AP)
complex 1 (AP-1) and AP-2, targeting trans-Golgi network
(TGN) and plasma membrane proteins to early endo-
somes, whereas SIV Nef also interacts with AP-3, which
participates in the direct transport of proteins from the
Golgi to lysosomes (Piguet and Trono, 1998; Bresnahan
et al., 1998; Greenberg et al., 1998; Craig et al., 2000).
Whereas it has been shown that SIV Nef binds to the
 chain of the TCR and down-modulates T cell surface
expression levels of both TCR and CD3 (Bell et al.,
1998), the regions on Nef that confer interaction and/or
down-modulation have not been fully elucidated. One
report mapped a critical domain to the large central core
domain of SIVmac239 Nef (amino acids 98–235) (Howe
et al., 1998), although the specific motifs and/or the
minimal domains crucial for interaction/down-modula-
tion of TCR  remained undefined. Identification of the
domains on SIV Nef involved in binding TCR  and
down-modulating the TCR/CD3 complex will provide in-
sight into the mechanism by which this occurs.
In this article we demonstrate that the ability to bind
TCR  at two independent and non-overlapping sites is
conserved among multiple SIV Nefs. Interaction of SIV
Nefs with either domain alone was sufficient to confer
Nef-mediated susceptibility of a CD8/TCR  fusion pro-
tein to down-modulation in mammalian cells. In contrast,
HIV-2 Nef bound strongly to the cytoplasmic domain of
TCR  at only the membrane distal SNID, but this inter-
action was insufficient for appreciable Nef-mediated
down-modulation of the TCR/CD3 complex. The interac-
tions between SIV and HIV-2 Nef, and TCR , were highly
specific since neither SIV nor HIV-2 Nef interacted with a
panel of other cell-surface signaling molecules contain-
ing tyrosine-based motifs homologous to that of SNID-1
or SNID-2 on TCR . Last, site-directed mutagenesis of
motifs on SIV Nef involved in endocytosis failed to affect
potent down-modulation of the TCR/CD3 complex. Only
mutagenesis of the myristoylation site and a conserved
region in the central core on SIV Nef abrogated down-
modulation of the TCR/CD3 complex, suggesting TCR/
CD3 down-modulation occurs via a mechanism that is
fundamentally different from CD4 and CD28 down-mod-
ulation.
RESULTS
Interaction of Nef with two homologous domains on
TCR  is conserved among diverse SIV Nefs
SIVmacJ5 (referred to here as macJ5) Nef and SIVmac239
(mac239) Nef interact with two non-overlapping, homol-
ogous domains on the invariant TCR  chain (Schaefer et
al., 2000), referred to as SNID-1 and SNID-2, for SIV Nef
Interaction Domain. To determine whether Nefs encoded
by sooty mangabey derived SIVs also interact with TCR 
via SNID-1 and SNID-2, we examined Nefs derived from
SIVsmmPBj (smmPBj) and SIVsmmB670 (smmB670).
SIVsmmPBj is a highly pathogenic molecular clone that
induces an unusually rapid and severe disease in rhesus
macaques, frequently resulting in death within 10 days of
inoculation (Fultz et al., 1989). SIVsmmB670 causes AIDS
3.5 to 6 months after infection in 50% of rhesus ma-
caques (Murphey-Corb et al., 1986; Murray et al., 1992).
The SIVmac239 molecular clone has been shown to cause
AIDS and death in approximately 50% of rhesus ma-
caques within 1 year of inoculation (Naidu et al., 1988),
whereas that of SIVmacJ5 causes AIDS and death in 15%
of rhesus macaques within 1 year of inoculation (Rud et
al., 1994). Additionally, we generated a deletion/insertion
mutant of SIVmac239 Nef (mac239r), in which amino acids
58–108 were removed and replaced with the sequence
IKKW, based on findings by Sawai et al. (2000), examin-
ing a series of revertant nef alleles obtained after infec-
tion with nef-deleted SIVmac239 viral constructs.
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The yeast two-hybrid system was employed to analyze
interactions between the different SIV Nefs and TCR 
subdomains. The SIV Nefs were stably expressed in
Saccharomyces cerevisiae strain Y190 as Gal4 DNA
binding domain (BD) fusion proteins and the resulting
strains were transformed with pACT2 constructs encod-
ing TCR  cytoplasmic domains fused to the Gal4 acti-
vation domain (AD) (Fig. 1A). Successful interaction be-
tween BD and AD fusion proteins induces the transcrip-
tion of the lacZ gene and transformants can be stained
for -galactosidase in a freeze-fracture, filter-lift assay
(Fig. 1B). All of the SIV BD/Nef fusion proteins interacted
with the full-length cytoplasmic domain of TCR  as well
as with subdomains containing either SNID-1 or SNID-2
(Fig. 1A; constructs AD/Human 52–164, AD/52–1641,
AD/52–1642, AD/52–1643, AD/52–110, AD/111–141,
AD/111–128, and AD/123–134). Likewise, AD/TCR  con-
structs containing neither SNID-1 nor SNID-2 (Fig. 1;
AD/52–1101, AD/111–126, and AD/127–164) failed to in-
teract with any of the SIV BD/Nef fusion proteins. As
expected, the cytoplasmic domain of CD2, a T cell sur-
face signaling and adhesion molecule, did not interact
with SIV BD/Nef (Fig. 1A; AD/CD2). Control analyses
performed in parallel in which each AD/TCR  fusion
domain was expressed in Y190 expressing Gal4 BD
alone provided no -galactosidase signal (data not
shown). These data demonstrate that interaction of SIV
Nef with both SNID-1 and SNID-2 of TCR  is a conserved
activity among SIVsmm and SIVmac Nefs.
We also examined multiple HIV Nefs for their abilities
to associate with and modulate TCR  in yeast two-
hybrid, pull-down, and cell-surface modulation assays.
The nef gene from the full-length infectious molecular
clone of HIV-2UC1 (Barnett et al., 1993) was included in
these analyses, as were the HIV-1 nef alleles encoded by
the prototypic T cell line adapted HIV-1 molecular clone,
BH10 (Ratner et al., 1985), and three additional nef alleles
obtained directly from patient material (Michael et al.,
1993). In the yeast two-hybrid assay, HIV-2UC1 Nef bound
both the full-length cytoplasmic domain of TCR  as well
as the TCR  subdomains containing SNID-1 and SNID-2
(Fig. 1A; constructs AD/Human 52–164, AD/52–110, and
AD/111–141, respectively). However, HIV-2UC1 Nef bound
the TCR  subdomain containing SNID-1 (construct AD/
52–110) sufficiently to generate only weak -galactosi-
dase staining intensity indicated by the “/” in Fig. 1A.
To determine if HIV-2UC1 Nef would interact more strongly
with SNID-1 when it was presented in a near full-length
context, we examined a construct in which ITAM 2 was
replaced with a hexa-alanine sequence (AD/52–1642),
and therefore lacked SNID-2. Again, HIV-2UC1 Nef inter-
acted only weakly with this near full-length AD/TCR 
construct containing only SNID-1. We next more specifi-
cally mapped the membrane distal determinant on TCR 
with which HIV-2UC1 Nef strongly interacted, using addi-
tional truncation mutants of TCR  (Fig. 1A). HIV-2UC1 Nef
failed to bind a TCR  subdomain that contained only
ITAM 2 (AD/111–126), suggesting that, similar to SIV Nef,
HIV-2UC1 Nef binds a domain that overlaps ITAM 2, in-
cluding the immediately downstream sequences. This
was confirmed by the demonstration that HIV-2UC1 BD/
Nef bound to both TCR  AD/111–128 and AD/123–134,
thereby mapping the HIV-2UC1 interaction domain on TCR
 to amino acids 123–128, which is identical to that for
macJ5 Nef (Schaefer et al., 2000), and mac239, smmPBj,
and smmB670 Nefs (Fig. 1A). In contrast, none of the
HIV-1 BD/Nefs bound to the full-length cytoplasmic do-
main of TCR  (construct AD/Human 52–164) in this
assay.
Interaction of SIV and HIV-2 Nefs with TCR  occurs
in the absence of additional eukaryotic cellular
factors
To determine whether interaction between smmB670,
smmPBj, mac239, and mac239r Nefs and TCR  occurred
without additional eukaryotic proteins, we expressed these
Nefs as GST-fusion proteins, and the cytoplasmic domains
of TCR  as hexahistidine (His)-tagged fusion proteins, in
Escherichia coli. GST/smmB670 Nef immobilized on glu-
tathione–sepharose beads pulled down the full-length TCR
 cytoplasmic domain from bacterial lysates (clone His/
Human 52–164), whereas immobilized GST did not (Fig. 2A).
Of the His-tagged fusion proteins examined (Fig. 2C), only
His-tagged TCR  subdomains containing either SNID-1 or
SNID-2 (clones His/52–110 and His/87–141, respectively)
were also pulled down by GST/smmB670 Nef, but not by
GST alone (Fig. 2A). Identical results were obtained in
pull-downs using GST fusion proteins containing smmPBj,
macJ5, mac239, or mac239r Nef (data not shown), indicat-
ing that multiple SIV Nefs interact with both SNID-1 and
SNID-2 within TCR  in the absence of additional eukaryotic
proteins.
To examine further the interaction between HIV-2UC1
FIG. 1. Interaction of SIV Nef with two homologous domains on TCR  is conserved among diverse SIV alleles and HIV-2 in a yeast two-hybrid assay.
(A) TCR  cytoplasmic domains were expressed as Gal4 AD fusion proteins in Y190 strains of S. cerevisiae stably expressing SIV, HIV-2, or HIV-1
BD/Nef fusion proteins. Replacement of ITAMs on TCR  with a stretch of six alanines is indicated by “” in the construct name. Interaction with the
BD/Nefs was determined in a filter-lift, freeze-fracture assay for -galactosidase. , interaction with BD/Nef; /, weak interaction with BD/Nef; ,
no interaction with BD/Nef. The Hck–SH3 AD fusion protein served as positive control for the HIV-1 Nefs. The CD2 AD fusion protein was included
as a negative control for interaction. Each interaction was examined in three independent experiments with identical results. Amino acid numbering
of the TCR  cytoplasmic domains follows that of Weissman et al. (1988). (B) Representative filter-lift -galactosidase assays in which the indicated
Gal4 AD fusion constructs were coexpressed in the mac239, macJ5, smmB670, and smmPBj BD/Nef-expressing strains of Y190.
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Nef and TCR , we used GST/HIV-2UC1 Nef to pull down
His-tagged domains of TCR  expressed in E. coli. As
demonstrated in Fig. 2B, GST/HIV-2UC1 Nef pulled down
the full-length cytoplasmic domain of TCR  as well as a
subdomain containing SNID-2 (His/Human 52–164 and
His/87–141, respectively). Concordant with the yeast two-
FIG. 2. Recombinant SIVsmmB670 and HIV-2UC1 Nefs interact with cytoplasmic domains of TCR  in the absence of additional eukaryotic proteins.
(A) GST/smmB670 Nef (top) and GST (bottom) proteins expressed in E. coli and immobilized on glutathione–sepharose beads were incubated with
bacterial lysates containing His-T7-tagged TCR  cytoplasmic domains. His-tagged proteins associated with GST/smmB670 Nef or GST were
analyzed by immunoblotting with the T7-specific monoclonal antibody. The GST/smmB670 and GST protein preparations used in these pull downs
were immobilized on glutathione–sepharose beads and then immunoblotted with GST-specific monoclonal antibody (right portion of panel). (B)
GST/HIV-2UC1 Nef (top), and GST (bottom) proteins expressed in E. coli and immobilized on glutathione–sepharose beads were incubated with
bacterial lysates containing His-T7-tagged TCR  cytoplasmic domains. Proteins associated with the GST/HIV-2UC1 Nef and GST coated beads were
analyzed by immunoblotting with the anti-T7 monoclonal antibody. The GST/HIV-2UC1 and GST protein preparations used in these pull downs were
immobilized on glutathione–sepharose beads and then immunoblotted with the GST-specific monoclonal antibody (right portion of panel). (C)
His-T7-tagged portions of the TCR  cytoplasmic domain were expressed in E. coli and purified using His-Bind resin (Novagen) and analyzed by
immunoblotting with the anti-T7 monoclonal antibody specific for an epitope present in all His-T7-tagged fusion proteins used in these studies. Shown
are representative data from one experiment repeated twice with similar results.
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hybrid data, GST/HIV-2UC1 Nef only weakly pulled down a
subdomain of TCR  containing SNID-1 (Fig. 2B; His/52–
110). Subdomains in which SNID-1 or SNID-2 were not
present were not pulled down by GST/HIV-2UC1 Nef (Fig.
2B; His/52–1101, and His/127–164). These data suggest
that HIV-2UC1 Nef binds TCR  via an interaction with
SNID-2 that is stronger than its interaction with SNID-1,
all in the absence of other eukaryotic proteins. Finally,
four GST/HIV-1 Nef fusion proteins were also examined
in parallel pull-down analyses and all failed to interact
with the full-length cytoplasmic domain of TCR  (data
not shown).
TCR  SNID-1 and SNID-2 confer susceptibility to SIV,
but not HIV-2, Nef-mediated down-modulation in
mammalian cells
Using expression vectors encoding chimeric proteins
containing the CD8 extracellular (EX) and transmem-
brane (TM) domains fused to portions of the TCR 
cytoplasmic domain, we examined whether HIV-1, HIV-2,
and SIV Nefs down-modulate surface proteins contain-
ing SNID-1 and SNID-2. 293T cells were cotransfected
with expression vectors encoding HIV or SIV Nef, and a
CD8/Hum  chimeric protein. Expression of smmB670,
smmPBj, macJ5, or mac239 Nefs resulted in the potent
down-modulation of cell-surface CD8/Hum  fusion pro-
tein containing the full-length cytoplasmic domain of TCR
 (construct CD8/Hum  52–164), whereas coexpression
of HIV-1 or HIV-2 Nefs failed to do so (Fig. 3A). These
data were concordant with yeast two-hybrid and pull-
down analyses which both demonstrated a lack of inter-
action between TCR  and HIV-1 Nef. However, it was
unexpected that HIV-2 Nef, which interacted with both
SNID-1 and SNID-2 in the yeast two-hybrid assay and
pull-down assays, failed to down-modulate the CD8/Hum
 chimeric protein containing the full-length cytoplasmic
domain of TCR . Further analyses with the SIV Nefs
demonstrated that constructs containing either SNID-1
(construct CD8/Hum  52–110) or SNID-2 (construct CD8/
Hum  111–141) were down-modulated from the cell
surface (Fig. 3B). When either ITAM 1 or ITAM 2 in the
respective TCR  subdomains was replaced with a hexa-
alanine sequence, thereby removing SNID-1 or SNID-2,
Nef-mediated down-modulation of the CD8/Hum  chi-
meric protein was abrogated (Fig. 3B; constructs CD8/
Hum  52–1101 and CD8/Hum  111–1412, respec-
tively). Similarly, when the cytoplasmic portion of the
CD8/ fusion protein consisted only of the C-terminal 38
amino acids of TCR , which contained neither SNID-1
nor SNID-2, the CD8/Hum  fusion protein was not down-
FIG. 3. TCR  SNID-1 and SNID-2 confer susceptibility to SIV Nef-mediated down-modulation in mammalian cells. The 293T cell line was transiently
transfected with plasmids encoding the indicated Nef and a CD8/TCR  fusion protein which was either the full-length cytoplasmic domain of TCR
 (A) or subdomains thereof (B). The cells were stained 48 h posttransfection with a PE-conjugated CD8-specific monoclonal antibody and analyzed
by flow cytometry with gating on live cells. These data are from one representative experiment repeated a minimum of two additional times with
similar results.
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modulated from the cell surface (Fig. 3B; construct CD8/
Hum  127–164). These data demonstrate that although
diverse SIV Nefs and HIV-2UC1 Nef bind both SNID-1 and
SNID-2 on TCR , these interactions confer susceptibility
only to SIV Nef-mediated down-modulation in mamma-
lian cells.
Interaction between SIV and HIV-2 Nefs and TCR  is
specific among a panel of cytoplasmic domains
containing tyrosine-based activation and endocytic
motifs
SIV and HIV-2UC1 Nefs interacted with domains on TCR
 that contain YxxL/I motifs present in ITAMs, which are
conserved motifs present in numerous transmembrane
signaling proteins. Therefore, we examined the abilities
of mac239 and HIV-2UC1 Nefs to interact with other cell-
surface proteins containing related tyrosine-based acti-
vation and endocytic motifs (TAMs). The patient-derived
HIV-1 Nef, IP2310, was also included in these analyses.
Using the yeast two-hybrid system, we examined binding
of Nef to the cytoplasmic domains of linker for activation
of T cells (LAT) (Zhang et al., 1998), brain immunoglobu-
lin-like molecule with TAMs (BIT) (Sano et al., 1997), T
cell receptor interacting molecule (TRIM) (Bruyns et al.,
1998), CD3, CD3, and FcRI (Turner et al., 1995). All of
these molecules are cell-surface transmembrane
adapter proteins that are known or thought to be involved
in cell signaling. As summarized in Fig. 4, all of these
molecules contain within their cytoplasmic domains two
or three canonical YxxL/I motifs. In the yeast two-hybrid
assay mac239, HIV-2UC1, and HIV-1 IP2310 Nefs all failed to
interact with any of the TAM-containing molecules ex-
cept TCR  (Fig. 4). In parallel, mac239, HIV-2UC1, and
HIV-1 IP2310 were expressed in E. coli as GST fusion
proteins that were then used in pull-down assays with
His6-tagged TAM-containing proteins. Concordant with
the yeast two-hybrid data, the mac239, HIV-2UC1, and
HIV-1 IP2310 GST-Nef fusion proteins all failed to pull
down any of the TAM-containing fusion proteins (data not
shown), except for His-tagged TCR  by mac239 and
HIV-2UC1 GST-Nefs. These data demonstrate, therefore,
that the interactions between SIV and HIV-2 Nefs and
TCR  are highly specific.
Mapping of determinants on SIVmac Nef important
for TCR  down-modulation
To determine if documented endocytic motifs present
on Nef are involved in the down-modulation of the TCR/
CD3 complex, SIVmac239 Nef was mutated in these
motifs (Fig. 5A). Additional regions on mac239 Nef tar-
geted for mutation were involved in the intracellular lo-
calization of Nef (G2A) (Cullen, 1994), down-modulation
of CD4 (YY28,39GG; YY60,65AA; and LM194,195AA) (Har-
ris et al., 1994), and interaction with cellular kinases
(PxxP/AxxA) (Khan et al., 1998; Lock et al., 1999; Piguet et
al., 1998; Bresnahan et al., 1999). Tyrosines Y60 and Y65
might also be important in the down-modulation of the
TCR/CD3 complex, given that deletion of amino acids
Q64 to N67 abolishes CD28 down-modulation by SIV-
mac239 Nef (Swigut et al., 2001). Two mutants disrupting
a highly conserved putative PKC phosphorylation motif
(referred to here as an Rx2S/TxK motif; Carl et al., 1999)
on mac239 Nef were also generated. Mutant 239 Nef
RSK/AAA was generated by replacing three amino acids
within the Rx2S/TxK motif (R109/S112/K114) with alanines,
whereas mutant 239 Nef 109–134 contained a deletion
of amino acids 109–134, which encompasses this entire
region. The Rx2S/TxK motif was targeted due to its im-
portance for SIV replication in rhesus macaques (Carl et
al., 1999) and because large deletion constructs of
FIG. 4. SIV and HIV-2 Nef interaction with cellular proteins containing tyrosine-based activation and endocytic motifs is specific for TCR . The
cytoplasmic domains of cell-surface proteins containing tyrosine-based activation and endocytic motifs are listed in the left column with encom-
passed amino acid sequences noted in parentheses. Their respective tyrosine-based activation and endocytic motifs are shown in the center column
with their amino acid locations in subscript. The amino acid sequences shown for TCR  are the minimal domains mediating interaction with SIV Nef
(YnELNL, SNID-1; YsEIGM, SNID-2). Amino acids in bold print indicate those critical for interaction with SIV Nef (TCR ) or signify the location of the
YxxL/I motif (LAT, BIT, TRIM, CD3, CD3, and FcRI). Interaction with the BD/Nefs in the yeast two-hybrid assay was determined in a filter-lift,
freeze-fracture assay for -galactosidase. , interaction with BD/Nef; , no interaction with BD/Nef. Each interaction was examined in three
independent experiments with identical results.
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FIG. 5. Schematic representation of deletion and substitution mutations in SIVmac239 Nef. (A) The SIVmac239 Nef constructs containing mutations
are shown schematically. Filled boxes represent deleted regions; “X” indicates amino acid substitutions, with specific substitution listed immediately
above. Interaction between the full-length cytoplasmic domain of TCR  and wild-type and mutant SIV mac239 Nefs was determined in a yeast
two-hybrid assay, shown to the right. , interaction with BD/Nef; , no interaction with BD/Nef. Each interaction was examined in three independent
experiments with identical results. (B) The deduced amino acid sequences (amino acids 109–134) of the SIV and equivalent amino acid sequences
of the HIV Nef proteins examined in this study are shown in alignment (aa91–116, HIV-2 Nef; aa77–102, HIV-1 Nefs). The threonine (T110), leucine
(L115), and isoleucine/tyrosine/tyrosine (IYY132–134) are highlighted to indicate nonconservative amino acids differences between SIV/HIV-2 and
HIV-1 Nefs.
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mac239 Nef missing this motif do not bind to TCR 
(Howe et al., 1998). An in vivo relevant deletion/insertion
mutant of SIVmac239 Nef (mac239r) mimicked a series of
revertant nef alleles obtained after infection of macaques
with nef-deleted SIVmac239 viral constructs (Sawai et al.,
2000). Combinations of mutations to endocytic motifs
were also examined using mac239r Nef as a backbone,
which lacks tyrosines YY60,65 and the kinase-binding
PxxP motif.
To examine the abilities of the mutant SIV Nefs to
modulate the expression of T cell surface proteins, while
simultaneously controlling for transfection efficiency and
Nef expression levels, we generated plasmids express-
ing the Nefs fused to the N-terminus of the enhanced
green fluorescent protein (EGFP) and transiently trans-
fected these vectors into the JJK T cell line. Using two-
color flow cytometry, we measured the levels of expres-
sion of T cell surface antigens CD4, CD28, CD3, TCR
/, and CD71, as a function of Nef-EGFP expression
levels (Fig. 6). To provide a measure of the down-modu-
lation of cell-surface molecules by Nef, we calculated the
percentage down-modulation based on the mean fluo-
rescent intensities (MFIs) for the PE surface stain in the
first and third decades of Nef-EGFP fluorescence (Fig. 7).
Interestingly, mutation of the endocytic motifs on SIV
Nef, including a mac239 Nef mutant with all known
endocytic motifs disrupted (239r Nef YYLM/GGAA), was
not impaired in its ability to down-modulate CD3 and
TCR / (Figs. 6 and 7). However, this Nef was impaired
in its ability to down-modulate CD4 and CD28 (Fig. 6).
The absence of involvement by endocytic motifs indi-
cated that the mechanism by which Nef-mediated down-
modulation of the TCR/CD3 complex occurred was fun-
damentally different from both CD4 and CD28 down-
FIG. 6. Flow cytometric analysis of JJK T cells transiently expressing SIV Nef-EGFP fusion proteins. The JJK T cell line was transiently transfected
with plasmid encoding EGFP or the indicated Nef-EGFP fusion protein. The cells were stained 48 h posttransfection for cell-surface CD3, TCR /,
CD4, CD28, or CD71 with PE-conjugated monoclonal antibodies and analyzed by two-color flow cytometry. Representative data are shown for a subset
of mac239 Nef mutants analyzed. These data were compiled from multiple experiments repeated a minimum of two additional times.
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modulation. Mutation of endocytic motifs on SIV Nef had
varying effects on CD4 and CD28 down-modulation.
While replacement of tyrosines Y28 and Y39 with gly-
cines (YY28,39GG) had a moderate effect on CD4 and
CD28 down-modulation, mutation of tyrosines Y60 and
Y65 and the leucine-based motif (YY60,65AA and LM/AA,
respectively) attenuated Nef’s ability to down-modulate
CD4 and, to a greater extent, CD28 (Fig. 7). Consistent
with the finding that tyrosines Y60 and Y65 are important
for down-modulation of CD28, mac239r Nef and derived
mutants, which all contained a deletion of amino acids
58–108, failed to down-modulate CD28. Mutations of the
putative Rx2S/TxK motif (109–134 and RSK/AAA) had
significant effects on Nef-mediated down-modulation
that were not limited to CD3 or TCR /, but included all
cell-surface proteins examined. Whereas mutant 239
RSK/AAA retained a limited capacity to down-modulate
CD3, CD4, and TCR /, mutant 239109–134 failed to
down-modulate any cell-surface protein examined (Fig.
7). A mutant of mac239 Nef lacking the myristoylation site
(G2A) failed to down-modulate any of the cell-surface
molecules examined. This was not unexpected since it
has been shown that localization of Nef to the inner
surface of the plasma membrane is crucial for many of
Nef’s activities (Harris, 1995; Goldsmith et al., 1995;
Greenway et al., 1994; Baur et al., 1997).
To identify further the amino acids within this region
(aa109–134) that might be critical to the down-modulation
of the TCR/CD3 complex, we aligned this region from
multiple strains of SIV and HIV (Fig. 5B). Having demon-
strated that down-modulation of the TCR/CD3 complex is
conserved among SIV Nefs and not among HIV-1 Nefs
(Fig. 1A), amino acid differences between these two
groups were identified for further analysis. Notably, there
was a conserved proline at position 110 in all HIV-1 Nefs
examined, and a conserved leucine at position 115 in all
SIV strains examined. In addition, a stretch of three
amino acids (IYY132–134) were again fully conserved
among all SIV Nefs, compared to a conserved sequence
of LIH for the HIV-1 Nefs. The tyrosine at position 134 of
HIV-1 307 and HIV-1 310 Nefs (amino acid nomenclature
based on SIV Nef sequence) suggested that Y134 might
not be critical for down-modulation of the TCR/CD3 com-
plex. Based on these comparisons four SIVmac239 Nef
mutants were generated: T110P, L115A, IY/LI (I132L and
Y133I), and IYY/LIH (I132L, Y133I, and Y134H) (Fig. 5A).
The T110P and L115A mutations had little effect on potent
down-modulation of the TCR/CD3 complex (Fig. 7). In
FIG. 7. Quantitative determination of cell-surface protein modulation by SIV Nefs. The mean fluorescence intensity (MFI) values for the PE surface
stain were calculated from the analyses represented as in Fig. 6. The percentage down-modulation was calculated as: [(MFIPE decade 1  MFIPE
decade 3)/(MFIPE decade 1)]  100. CD3 (black bars); TCR / (dark gray bars); CD4 (light gray bars); CD28 (white bars). Data were compiled from
a minimum of two independent experiments, and error bars represent the standard deviation.
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contrast, the IY/LI mutation and to a greater extent the
IYY/LIH mutation were attenuated in their ability to down-
modulate the TCR/CD3 complex (Fig. 7). Similar to mu-
tations made to the Rx2S/TxK motif (109–134 and RSK/
AAA), mutations made to IY and IYY attenuated not only
the down-modulation of the TCR/CD3 complex, but also
the down-modulation of both CD4 and CD28. All of the
mac239 Nef mutants interacted with the cytoplasmic
domain of TCR  in the yeast two-hybrid assay except for
239 109–134 Nef (Fig. 5A), which likely contributes to
the inability of this mutant to down-modulate CD3 and
TCR /. In summary, multiple amino acids in the con-
served central region of Nef (109–134) are involved in
down-modulation of the TCR/CD3 complex, whereas
amino acids in documented endocytic motifs are not
involved in this conserved activity.
DISCUSSION
We have presented here evidence that the interaction
between SIV Nef and the TCR  chain is likely to be an
important aspect of Nef’s contribution to pathogenic vi-
rus/host interactions. First, the ability to bind to TCR  on
two separate domains and down-modulate the TCR/CD3
complex was conserved among all SIVmac and SIVsmm
Nefs examined, indicating these activities are not unique
to a single SIV nef allele. Second, the association be-
tween SIV Nef and TCR  is highly specific. Examination
of six additional transmembrane signaling adaptor pro-
teins, containing two or more YxxL/I motifs, demon-
strated that SIV Nef interacted with only TCR  in both
yeast two-hybrid and pull-down assays. This specificity
for the YxxL sequences contained in the TCR  SNIDs
indicates that SIV Nef does not have a broad affinity for
tyrosine-based motifs. Third, an SIV nef allele (mac239r)
modeled after in vivo selected Nef revertants (Sawai et
al., 2000), and which had a 50 amino acid deletion within
the conserved central core of Nef, also bound TCR  on
two separate domains and down-modulated the TCR/
CD3 complex. Collectively, these data suggest there are
strong selective pressures for SIV Nef to associate with
and modulate TCR  in vivo.
The mechanism by which SIV Nef modulates the sur-
face expression levels of the TCR/CD3 complex was
examined by mutating key motifs on an SIV mac239 Nef
backbone. Remarkably, the ability of SIV Nef to associate
with TCR  and down-modulate the TCR/CD3 complex
was highly tolerant to mutation of motifs demonstrated
previously to be important for either association with the
cellular endocytic machinery or with protein kinases.
Mutation of an N-terminal tyrosine-based motif (Y28,Y39),
a more distal tyrosine-based motif (Y60,65), and C-termi-
nal dileucine motif (L94,M95), even all together, did not
abrogate SIV Nef’s ability to down-modulate the TCR/
CD3 complex. However, mutation of these motifs did
inhibit, with varying severities, Nef’s ability to down-
modulate CD4, and to a greater extent, CD28. Regions on
SIV Nef that were important for down-modulation of the
TCR/CD3 complex were the myristoylation site (mutant
G2A) and a stretch of conserved amino acids from posi-
tion 109 to 134 (mutants 109–134, RSK/AAA, IY/LI, and
IYY/LIH), which contained a putative PKC phosphoryla-
tion site (Rx2S/TxK) (Carl et al., 1999). The mac239 G2A
Nef mutant likely lost its ability to down-modulate all
cell-surface molecules examined due to failure of Nef to
localize at the inner surface of the plasma membrane. In
addition, the normal transport of the G2A Nef from the ER
to the plasma membrane is likely disrupted, thereby
reducing Nef’s ability to associate with other proteins,
such as TCR , that are trafficking along the same bio-
genic pathway. Disruption of the Rx2S/TxK motif impaired
SIV Nef’s ability to down-modulate the TCR/CD3 com-
plex. Whereas mac239 RSK/AAA Nef retained limited
ability to down-modulate CD4, CD28, CD3, and TCR /,
mac239 109–134 Nef lost all ability to modulate these
cell-surface molecules. Nef’s ability to down-modulate
these cell-surface molecules was also impaired by mu-
tation of amino acids 132–134 (IYY), although to a lesser
extent. We were unable to identify a single determinant
on Nef that was critical only to the down-modulation of
the TCR/CD3 complex, since disruptive mutations re-
sulted in the impaired down-modulation of all cell-sur-
face molecules examined (CD4, CD28, CD3, and TCR
/). It is possible that disruption of this region severely
alters the local or overall conformation of Nef, preventing
it from associating with its cellular partners. Alternatively,
phosphorylation by PKC might facilitate downstream ac-
tivities of SIV Nef, although the Rx2S/TxK motif, while
conserved, has not been shown definitively to mediate
this function in vitro. Further analyses are required to
determine precisely how this region of Nef is contribut-
ing to its ability to modulate the TCR/CD3 complex.
In contrast to down-modulation of CD4 and CD28,
motifs on mac239 Nef that are crucial for the down-
modulation of the TCR/CD3 complex are not those that
mediate Nef’s interaction with the protein-trafficking ma-
chinery, indicating that there are aspects to the mecha-
nism of TCR/CD3 complex down-modulation that are
fundamentally different than those of CD4 and CD28
down-modulation. Interaction of SIV Nef with TCR  could
be sufficient to interfere with the biogenesis of the TCR/
CD3 complex, since the  chain is crucial for complete
formation of the TCR/CD3 complex at the cell surface. As
demonstrated in Fig. 6, Nef must reach a threshold con-
centration before down-modulation of the TCR/CD3 com-
plex is observed. At this concentration of Nef, the avail-
ability of the  chain may be insufficient for the mainte-
nance of steady-state levels of surface TCR/CD3
complex.
If there are selective pressures on SIV Nef to maintain
the ability to modulate the TCR/CD3 complex, specifically
associating with TCR  would be an efficient strategy by
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which to do this. TCR  is an excellent modulatory target
as it is the rate-limiting component in the biogenesis and
assembly of the TCR/CD3 complex prior to its transloca-
tion to the cell surface (Irving and Weiss, 1991; Love et
al., 1993; Shores et al., 1994). Furthermore, dissociation
of TCR  from the TCR/CD3 complex at the cell surface
results in endocytosis and lysosomal targeting of the
remaining TCR components (Dietrich and Geisler, 1998;
Klausner et al., 1989; Sussman et al., 1988). One potential
benefit SIV might achieve by down-modulating the TCR/
CD3 complex is the promotion or the maintenance of an
infected T-lymphocyte in a more quiescent state, thereby
prolonging the duration of virus production by that cell.
Alternatively, down-modulating the TCR/CD3 complex in
individual infected cells might contribute incrementally to
reduction of virus-specific immune responses, with a
resulting parallel reduction in global immune responses.
Whether SIV and HIV-2 Nef interactions with TCR  have
inhibitory effects on TCR signal transduction at levels of
expression that are below a threshold required for down-
modulation remains to be determined. However, manip-
ulation of the TCR/CD3 signal transduction cascade is an
effect already demonstrated by both SIV and HIV Nefs
(Baur et al., 1994b; Du et al., 1995; Garcia and Miller,
1991; Graziani et al., 1996; Luria et al., 1991; Skowronski
et al., 1993), and regardless of the mechanisms and
interactions involved, there might be advantages to the
virus when this signaling pathway is disrupted. Although
the data presented here indicate that Nef down-modu-
lates T cell surface proteins involved in activation and
stimulation, these activities do not preclude the potential
for Nef to alter the intracellular milieu to enhance viral
replication. Activation of cellular kinases, by interaction
and/or association with Nef, could result in increased
levels of cellular transcription factors essential for viral
replication in cells that are nevertheless reduced in their
abilities to receive activation signals through the TCR/
CD3/CD4 complex.
Having demonstrated that HIV-2 Nef associated with
TCR  (Figs. 1A and 2), it was unexpected that HIV-2 Nef
failed to down-modulate the CD8/Hum  52–164 fusion
protein (Fig. 3) or the TCR/CD3 complex (Bell et al., 2001).
One possibility is that the stronger interaction between
SIV Nef and the membrane-proximal SNID in ITAM 1 is a
determinant of the extent of down-modulation. Alterna-
tively, simultaneous association with other cellular fac-
tors might be important in reducing surface levels of the
TCR/CD3 complex. Examination of a larger number of
HIV-2 nef alleles is required to determine whether HIV-2
Nefs are inherently unable to modulate the expression of
the TCR/CD3 complex from the cell surface, or whether
this is unique to the HIV-2UC1 allelic form. In contrast to
SIV and HIV-2 Nefs, four HIV-1 Nefs failed to interact with
TCR  in all assays presented here. These data are
consistent with findings by Howe et al. (1998), but differ
from findings by Xu et al. (1999). It is possible that if HIV-1
Nef associates with TCR , the association could be
dependent upon the context and/or phosphorylation
state of TCR  or might be dependent on the presence of
other T cell specific factors. Regardless of the possible
requirements for association between HIV-1 Nef and
TCR , we did not observe potent down-modulation of
CD3 or TCR / by multiple HIV-1 Nefs. The conserved
ability of SIV Nef to interact with TCR  and down-
modulate the TCR/CD3 complex might contribute to the
more rapid rate of disease progression in SIV-infected
macaques relative to HIV-1- or HIV-2-infected humans.
In summary, the data we have presented here indicate
that the extent to which a given Nef protein reduces
cell-surface expression of the TCR/CD3 complex lies
within a spectrum of activities. At one extreme is SIV Nef,
multiple alleles of which potently down-modulate the
TCR/CD3 complex through interaction with two binding
domains on TCR . At the other end of the spectrum is
HIV-1 Nef, which does not interact with TCR . In be-
tween these extreme phenotypes lies HIV-2, which de-
spite interacting strongly with TCR  on one of the two
SNIDs, fails to down-modulate the TCR/CD3 complex.
Furthermore, we have demonstrated that none of the
currently known endocytic motifs found on SIV Nef are
crucial for down-modulation of the TCR/CD3 complex
and, thus far, only the mutation of the myristoylation site
or a 26 amino acid region containing a conserved Rx2S/
TxK motif abrogated this activity. Further analyses are
required to clarify the biochemical and biological differ-
ences in the associations between SIV, HIV-2, and HIV-1
Nef with the TCR  chain, as well as the contribution that
these highly specific interactions make to the pathogenic
process.
MATERIALS AND METHODS
Generation and analysis of yeast strains
All manipulations of the Y190 strain of S. cerevisiae
(Harper et al., 1993) followed standard yeast genetic
methods (Johnston, 1994) and have been fully described
(Fuller et al., 1998; Bell et al., 1998; Schaefer et al., 2000).
Recombinant yeast strains stably expressing fusion pro-
teins of the Gal4 DNA binding domain and Nef (BD/Nef)
were generated by targeted integration of the plasmid
vector, pYTH9 (Fuller et al., 1998), into the trp1 locus of
strain Y190 as described (Fuller et al., 1998). Interactions
between BD/Nef fusion protein and Gal4 AD fusion pro-
teins expressed by pACT2 were examined in S. cerevi-
siae Y190 expressing the SIVmacJ5, SIVmac239, SIVmac239
mutants, SIVsmmB670, SIVsmmPBj, HIV-1BH10, HIV-1SP1.102,
HIV-1IP2.307, HIV-1IP2.310, or HIV-2UC1 BD/Nef fusion proteins
as described (Fuller et al., 1998). The nomenclature of the
BD and AD fusion proteins has been changed from
previous reports (Schaefer et al., 2000) to better reflect
the location of the BD or AD within the fusion protein.
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PCR and subcloning of SIV nef genes
The SIVmacJ5, SIVmac239, SIVsmmPBj, and SIVsmmB670
Nef expression vectors have been described previously
(Bell et al., 1998, 2001). pSA90 mammalian expression
vectors containing the SIVmacJ5, SIVmac239, SIVsmmPBj, and
SIVsmmB670 nef genes were restriction digested with
EcoRI and gel-isolated inserts were ligated to identically
prepared pGEX-3X. The mac239r nef gene was gener-
ated by overlap extension PCR in which the deletion of
51, and insertion of 4 (IKKW), amino acids were specified
within the overlapping sequences. Using pSA90.239open
(Bell et al., 1998) as DNA template, primers TRSIVtNef-
For() (5-GGAATCAAGAAGTGGAGAACAATGAGTTAC-
AAAT3) and IB3N() (5-ACACTCGAGGAATTCTCAGC-
GAGTTTCCTTCTTGT-3) were used to amplify the se-
quences downstream of the IKKW insertion and primers
TRSIVtNefRev() (5-TCTCCACTTCTTGATTCCCTCACA-
AGAGAGTGAGCTCAA-3) and IB5N() (5-ACACGAAT-
TCAATGGGTGGAGCTATTTCC-3) were used to amplify
the sequences upstream of the insertion. Primers
IB5N() and IB3N() were then used to generate
mac239r nef using the two first-round products as tem-
plate. The YY28/39GG mutant of SIVmac239 Nef was gen-
erated by overlap extension PCR in which the substitu-
tion of tyrosines 28 and 39 with glycine residues were
specified within the overlapping sequences. Using
pSA90.239open (Bell et al., 1998) as DNA template, prim-
ers TRSN9YYMUT2() (5-CTCTTAGGAGAGGTGGAAG-
ATGGAGGCTCGCAATCCCCAGG-3) and IB3N() were
used to amplify the sequences downstream of the mu-
tation and primers TRSNEFYYMUT2() (5-TCCACCT-
CTCCTAAGAGTCTCCCACCAGTCTCCCCACGC-3) and
IB5N() were used to amplify the sequences upstream
of the insertion. Primers IB5N() and IB3N() were
then used to generate mac239 YY28/39GG nef using the
two first-round products as template. The YY60/65AA
mutant of SIVmac239 Nef was generated by overlap ex-
tension PCR in which the substitution of tyrosines 60 and
65 with alanine residues were specified within the over-
lapping sequences. Using pSA90.239open (Bell et al.,
1998) as DNA template, primers TRYY60AA() (5-AGC-
CAATCAGGGACAGGCTATGAATACTCCATGGAGAAACC-
3) and IB3N() were used to amplify the sequences
downstream of the mutation and primers TRYY60AAR()
(5-TAGCCTGTCCCTGATTGGCTTTCTGTGCCTCACAAG-
AGAGT-3) and IB5N() were used to amplify the se-
quences upstream of the insertion. Primers IB5N() and
IB3N() were then used to generate mac239 YY60/
65AA nef using the two first-round products as template.
Using pSA90.239open (Bell et al., 1998) as DNA template,
primers 239MyrMut() (5-GCAAGCTTACCATGGCTG-
GAGCTATTTCC-3) and IB3N() were used to generate
mac239 G2A nef. The 109–134 mutant of SIVmac239 Nef
was generated by overlap extension PCR in which the
deletion of amino acids 109–134 were specified within
the overlapping sequences. Using pSA90.239open (Bell
et al., 1998) as DNA template, primers 239d109–134F()
(5-AGTGCAAGAAGACATAGAATC-3) and IB3N() were
used to amplify the sequences downstream of the dele-
tion and primers 239d109–134R() (5-TCTATGTCTTCTT-
GCACTTAGGGGAACTTTTGG-3) and IB5N() were
used to amplify the sequences upstream of the insertion.
Primers IB5N() and IB3N() were then used to gen-
erate mac239 109–134 nef using the two first-round
products as template. The RSK/AAA mutant of SIVmac239
Nef was generated by overlap extension PCR in which
the substitution of amino acids R109/S112/K114 with ala-
nines was specified within the overlapping sequences.
Using pSA90.239open (Bell et al., 1998) as DNA template,
primers 239RSK/AAAF() (5-GCAACAATGGCTTACG-
CATTGGCAATAGACATG-3) and IB3N() were used to
amplify the sequences downstream of the substitution
and primers 239RSK/AAAR() (5-TGCGTAATCCATTGTT-
GCTAGGGGAACTTTTGG-3) and IB5N() were used to
amplify the sequences upstream of the substitution.
Primers IB5N() and IB3N() were then used to am-
plify mac239 RSK/AAA nef using the two first-round prod-
ucts as template. The 239rNef YY28/39GG mutant of
SIVmac239 Nef was generated by overlap extension PCR.
Using 239.YY28/39GG.pYTH9 as DNA template, primers
TRSIVtNefFor() and IB3N() were used to amplify the
sequences downstream of the YY28/39GG substitution
and primers TRSIVtNefRev() and IB5N() were used
to amplify the sequences upstream of the substitution.
Primers IB5N() and IB3N() were then used to am-
plify mac239rNef YY28/39GG nef using the two first-
round products as template. The 239rNef LM194/195AA
mutant of SIVmac239 Nef was generated by overlap ex-
tension PCR. Using 239.LM194/195AA.pYTH9 as DNA
template, primers TRSIVtNefForEXT() (5-GGAATCAA-
GAAGTGGAGAACAATGAGTTACAAATTGG-3) and
IB3N() were used to amplify the sequences down-
stream of the LM194/195AA substitution and primers
TRSIVtNefRev() and IB5N() were used to amplify the
sequences upstream of the substitution. Primers
IB5N() and IB3N() were then used to amplify
mac239rNef LM/AA nef using the two first-round prod-
ucts as template. The 239rNef YYLM28/39/194/195GGAA
mutant of SIVmac239 Nef was generated by overlap ex-
tension PCR. Using pGEMT.239.rNef.LM/AA as DNA
template, primers TRSN9YYMUT2() and IB3N() were
used to amplify the sequences downstream of the YY28/
39GG substitution and primers TRSNEFYYMUT2() and
IB5N() were used to amplify the sequences upstream
of the substitution. Primers IB5N() and IB3N() were
then used to amplify mac239rNef YYLM/GGAA nef using
the two first-round products as template. The 239 T110P
Nef mutant of SIVmac239 Nef was generated by overlap
extension PCR. Using pSA90.239open as DNA template,
primers SnefT110PF() (5-CCCCTAAGACCAATGAGT-
TAC-3) and IB3N() were used to amplify the se-
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quences downstream of the T110P substitution and prim-
ers SnefT110PR() (5GTAACTCATTGGTCTTAGGGG-3)
and IB5N() were used to amplify the sequences up-
stream of the substitution. Primers IB5N() and
IB3N() were then used to amplify mac239 T110P nef
using the two first-round products as template. The 239
L115A Nef mutant of SIVmac239 Nef was generated by
overlap extension PCR. Using pSA90.239open as DNA
template, primers SnefL115AF() (5-ATGAGTTACAA-
AGCGGCAATAGACATG-3) and IB3N() were used to
amplify the sequences downstream of the L115A substi-
tution and primers SnefL115AR() (5-CATGTCTATTGC-
CGCTTTGTAACTCAT-3) and IB5N() were used to am-
plify the sequences upstream of the substitution. Primers
IB5N() and IB3N() were then used to amplify
mac239 L115A nef using the two first-round products as
template. The 239 IY/LI and 239 IYY/LIH Nef mutants of
SIVmac239 Nef were generated by overlap extension PCR.
Using pSA90.239open as DNA template, primers Sne-
fIYY/LIHF() (5-GGACTGGAAGGGCTTATTYACAGTGC-
AAGAAGA-3) and IB3N() were used to amplify the
sequences downstream of the IYY/LIH substitution and
primers SnefIYY/LIHR() (5-TCTTCTTGCACTGTRAATA-
AGCCCTTCCAGTCC-3) and IB5N() were used to am-
plify the sequences upstream of the substitution. Primers
SnefIYY/LIHF() and SnefIYY/LIHR() contain mixed py-
rimidine and purine bases (in bold), respectively, that
result in either mutation IY/LI or IYY/LIH. Primers
IB5N() and IB3N() were then used to amplify
mac239 IY/LI and mac239 IYY/LIH nefs using the two
first-round products as template. PCR products were
restriction digested with EcoRI, subcloned into the mam-
malian expression vectors pSA90, pYTH9, and/or pGEX-
3X, and DNA sequenced. The generation of mac239
expression vectors containing mutations H196Q, LM194/
195AA, or PxxP/AxxA have been described (Bell et al.,
2001). Each mutant of SIVmac239 nef, except mac239
G2A, was amplified with primers IB5N() and 3SNef-
GFP (5-ACACGGATCCGCGAGTTTCCTTCTTGTC-3), re-
striction digested with EcoRI and BamHI, subcloned into
appropriately prepared pEGFP-N3 (Clontech) vector, and
DNA sequenced. SIVmac239 G2A was amplified using
primer 239MyrMut() instead of primer IB5N(). SIV-
macJ5 (Bell et al., 1998), SIVmac239 (Bell et al., 1998),
SIVsmmPBj (Bell et al., 2001), and SIVsmmB670 (Bell et
al., 2001) Nef-EGFP expression vectors have been de-
scribed (Bell et al., 1998, 2001).
PCR and subcloning of HIV nef genes
The HIV-1 SP1102 nef gene was amplified by PCR with
Taq polymerase according to the manufacturer’s recom-
mendation with primers HIVNEF5() (5-CGCGAATTC-
CATGGGTGGCAAGTGGTCA-3) and HIVNEF3-1()
(5-CGCGAATTCGCGGCCGCTCAGCAGTTCTTGTAGTA-3)
using pCD3.SP1.102 DNA as template (kindly provided by
N. Michael). The HIV-1 IP2307 and HIV-1 IP2310 nef genes
were similarly amplified with primers HIVNEF5() and
HIVNEF3-2() (5-CGCGAATTCGCGGCCGCTCAG-
CAGTCTTTGTAGTA-3) using pCD3.IP2.307 and
pCD3.IP2.310 DNA as templates (kindly provided by N.
Michael), respectively. PCR products were restriction di-
gested with EcoRI, subcloned into pSA90 or pGEX-3X
vectors, and DNA sequenced. EcoRI/NotI inserts were
then subcloned into the yeast Gal4 BD expression vector
pYTH9. The HIV-1 BH10 nef was amplified with primers
CAHIV2 (5-TCGATGAATTCAGCAGTTCTTGAAGTACTCC-
3) and cc832() (5-CGTGGATCCATGGGTGGCAAGTG-
GTCAAAAAG-3) using pB305 (GlaxoWellcome Institute
for Molecular Biology in Geneva) as template. PCR prod-
ucts were restriction digested with EcoRI and BamHI,
subcloned into pGEX-2T (Pharmacia), and DNA se-
quenced. Additionally, HIV-1 BH10 nef was amplified with
primers CAHIV1() (5-GACGGCCATGGGTGGCAAGTG-
GTCAAAAAG-3) CAHIV2() using pB305 (GlaxoWell-
come Institute for Molecular Biology) as DNA template,
and the resulting products were restriction digested with
EcoRI and NcoI, subcloned into pYTH9, and DNA se-
quenced. BH10 nef was also amplified with primers HIV-
NEF5() and HIVNEF3() using pGEX-2T-Nef-BH10
DNA template, and the resulting products were restric-
tion digested with EcoRI, subcloned into the mammalian
expression vector pSA90, and DNA sequenced. Using
HIV-2UC1 viral supernatant directly as template (kindly
provided by J. Levy), the nef gene from HIV-2UC1 was
generated by RT-PCR (Promega) with primers
HIV2UC15() (5-CGCGAATTCCATGGGATCAGCTGGT-
TCC-3) and HIV2UC13() (5-CGCGAATTCGCGGC-
CGCTCACTCCTTCTCTGGTAA-3). The resulting prod-
ucts were restriction digested with EcoRI, subcloned into
pSA90 or pGEX-3X, and DNA sequenced. EcoRI/NotI
inserts were then subcloned into the yeast expression
vector pYTH9. HIV-2 (Barnett et al., 1993) and HIV-1
(Michael et al., 1993) Nef-GFP expression vectors have
been described (Bell et al., 1998, 2001).
PCR and subcloning of cDNAs encoding cellular
tyrosine-based activation and endocytic motifs
CD2, TCR , and Hck Src homology 3 domain (SH3
domain) expression constructs have been previously de-
scribed (Bell et al., 1998; Schaefer et al., 2000). Sequences
encoding the cytoplasmic domain of linker for activation
of T cells were amplified with primers LATCYT5()
(5-GCCGAATTCTTAGACTGCCAGGCTCCTACGAC-3)
and LAT3() (5-GCCGGATCCTCGAGTCAGTTCAGCTC-
CTGCAGATTCT-3) using pEF/Bos:LAT as DNA template
(Zhang et al., 1998) (kindly provided by L. Samelson).
Sequences encoding the cytoplasmic domain of brain
immunoglobulin-like molecule with TAMs were amplified
with primers BITF1() (5-ACACGAATTCTACGGATCAA-
ACAGAAGAAAGCC-3) and BITR1() (5-ACACCTCGAG-
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TCACTTCCTCTGGACCTGGAC-3) using pKS-BIT as
template (Sano et al., 1997) (kindly provided by S. Sano).
Sequences encoding the cytoplasmic domain of T cell
receptor interacting molecule were amplified with
primers TRIMF1() (5-ACACGAATTCTATTCAATATTTC-
CCACTATGTG-3) and TRIMR1() (5-ACACCTCGAGCT-
AGTTTATAGGTTCTCTCTT-3) using pEF-Bos:TRIM as
template (Bruyns et al., 1998) (kindly provided by E.
Bruyns). PCR products generated for LAT, BIT, and
TRIM were restriction digested with EcoRI and XhoI,
subcloned into pACT2 or pET28c (Clontech; Novagen),
and DNA sequenced. Poly(A) RNA was prepared from
the JJK Jurkat T cell line using the PolyATract kit (Pro-
mega) and used as template to obtain CD3 and CD3
partial cDNAs. Sequences encoding the cytoplasmic do-
main of CD3 were obtained by RT-PCR using the prim-
ers CD3E.F.CYT (5-ACACGGATCCTGAATAGAAAGGC-
CAAGGCCAAGCC-3) and CD3E.R (5-ACACCTCGAGT-
CAATTCCTCCTCAACTG-3), and sequences encoding
the cytoplasmic domain of CD3 were obtained with
primers CD3G.F.CYT (5-ACACGGATCCTGGATGGAGT-
TCGCCAGTCG-3) and CD3G.R (5-ACACCTCGAGTCAA-
TTCCTCCTCAACTG-3). Poly(A) RNA was also pre-
pared from the U937 pre-promonocytic cell line using the
PolyATract kit (Promega) and used as template to obtain
the FcRI partial cDNA. Sequences encoding the cyto-
plasmic domain of FcRI were obtained by RT-PCR
using the primers FC.E.RIG.F (5-ACACGGATCCTGC-
GACTGAAGATCCAAGTG-3) and FC.E.RIG.R (5-ACAC-
CTCGAGCCACTGTGGTGGTTTCCC-3). The resulting
products were restriction digested with EcoRI and XhoI,
subcloned into pACT2 or pET28c, and DNA sequenced.
The CD3, CD3, and FcRI coding sequences ob-
tained were compared with their respective published
sequences and demonstrated to be identical (Duester et
al., 1986; Gold et al., 1986; Krissansen et al., 1986).
Expression of recombinant proteins in E. coli and use
in pull-down assays
Generation of (glutathione-S-transferase) GST-Nef and
His6 fusion proteins and use in pull-downs were per-
formed as described (Schaefer et al., 2000). The nomen-
clature of the GST and His-tagged fusion proteins has
been changed from previous reports (Schaefer et al.,
2000) to better reflect the location of the GST or His
within the fusion protein.
Cells and transfections
Electroporation and flow cytometric analyses of the
CD4 Jurkat T cell line, JJK (kindly provided by D. Littman)
and the 293T cell line (ATCC No. 45504; American Type
Culture Collection) were performed as described
(Schaefer et al., 2000).
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